The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksReckitt Regulatory News (RKT)

Share Price Information for Reckitt (RKT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4,599.00
Bid: 4,598.00
Ask: 4,599.00
Change: 2.00 (0.04%)
Spread: 1.00 (0.022%)
Open: 4,585.00
High: 4,615.00
Low: 4,577.00
Prev. Close: 4,597.00
RKT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director Appointment and Committee Changes

16 Feb 2024 07:00

RNS Number : 3578D
Reckitt Benckiser Group PLC
16 February 2024
 

RECKITT BENCKISER GROUP PLC

 

APPOINTMENT OF FIONA DAWSON CBE

AND REMUNERATION COMMITTEE CHANGES

 

Reckitt Benckiser Group plc (the "Company" or "Reckitt") today announces the appointment of Fiona Dawson CBE to the Board as a Non-Executive Director and as Chair Designate to the Remuneration Committee effective 1 June 2024.

 

Fiona is currently a Non-Executive Director of Marks and Spencer Group plc where she is a member of their Nomination and Remuneration Committees, and a Non-Executive Director of LEGO and of Kerry Group plc, where she is also a member of their Remuneration Committee. Fiona brings extensive consumer products experience. She was previously Global President Food, Drinks and Multisales at Mars, Inc. sitting on the Global Leadership Team. Fiona rose from the Graduate Trainee scheme to roles including President of Global Retail and Mars Chocolate UK and European Marketing Vice President where she made an enduring impact in her three decades at the business. Fiona has a strong track record in sustainability, health and wellbeing, particularly women's entrepreneurship and human rights. In May 2021, Fiona was awarded a CBE for services to women and the economy. She is Chair of the Women's Business Council, President Elect of the Chartered Management Institute and a Trustee with the Social Mobility Foundation.

 

Alan Stewart, Non-Executive Director and Chair of the Remuneration Committee, has informed the Company of his intention to retire from the Board with effect from the conclusion of the Company's Annual General Meeting ("AGM") to be held on 2 May 2024. 

 

In order to ensure continuity and effective succession, the Nomination Committee, and subsequently the full Board, has agreed that Mary Harris, Designated Non-Executive Director for Engagement with the Company's Workforce and former Chair of the Company's Remuneration Committee, be reappointed as Chair of the Remuneration Committee from the conclusion of this year's AGM until the conclusion of the Company's 2025 AGM. Although Mary has now served nine years as a Non-Executive Director of the Company, the Board unanimously agreed that Mary is uniquely positioned to undertake the role during this interim period due to her extensive knowledge of the business, her in-depth understanding of investor and other stakeholder expectations, and previous experience as a former chair of the remuneration committees of the Company, Unibail-Rodamco-Westfield S.E. and J Sainsbury plc. 

 

In so doing, this will enable Fiona Dawson to serve a year on the Company's Remuneration Committee before assuming the role of Chair of the Remuneration Committee following the Company's 2025 AGM.

 

Elane Stock will succeed Mary as the Designated Non-Executive Director for Engagement with the Company's Workforce following the conclusion of this year's AGM.

 

Commenting on the appointment, Chris Sinclair, Chair of the Board said:

 

"I would like to thank Alan for his contribution to our Board and Remuneration Committee. We wish him every success in the future. We are delighted that Fiona Dawson will be joining the Reckitt Board as the long-term Chair of the Remuneration Committee. She brings extensive consumer products experience from her three decades at Mars and has a passionate commitment to sustainability, health and wellbeing, particularly women's entrepreneurship and human rights. I also sincerely thank Mary and Elane for their ongoing commitment to the Company in assuming their respective roles following the AGM."

 

The Company confirms that there is no further information to be disclosed under the requirements of Listing Rule 9.6.13R in relation to Fiona Dawson's appointment.

 

 

Contacts Details:

 

 

Catheryn O'Rourke +44 (0) 1753 217 800

General Counsel & Company Secretary

 

 

Richard Joyce +44 (0)7807 418516

Investor Relations

 

 

About Reckitt:

 

Reckitt* exists to protect, heal and nurture in the relentless pursuit of a cleaner, healthier world. We believe that access to the highest-quality hygiene, wellness and nourishment is a right, not a privilege.

 

Reckitt is the company behind some of the world's most recognisable and trusted consumer brands in hygiene, health and nutrition, including Air Wick, Calgon, Cillit Bang, Clearasil, Dettol, Durex, Enfamil, Finish, Gaviscon, Harpic, Lysol, Mortein, Mucinex, Nurofen, Nutramigen, Strepsils, Vanish, Veet, Woolite and more.

 

Every day, more than 20 million Reckitt products are bought globally. We always put consumers and people first, seek out new opportunities, strive for excellence in all that we do and build shared success with all our partners. We aim to do the right thing, always.

 

We are a diverse global team of c. 40,000 colleagues. We draw on our collective energy to meet our ambitions of purpose-led brands, a healthier planet and a fairer society. Find out more, or get in touch with us at www.reckitt.com

 

* Reckitt is the trading name of the Reckitt Benckiser group of companies

 

Reckitt Benckiser Group plc's LEI code is 5493003JFSMOJG48V108

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAQKPBDKBKBFBD
Date   Source Headline
4th Jan 20247:00 amRNSTransaction in Own Shares
3rd Jan 20247:00 amRNSTransaction in Own Shares
2nd Jan 202412:19 pmRNSTotal Voting Rights
2nd Jan 20247:00 amRNSTransaction in Own Shares
29th Dec 20237:00 amRNSTransaction in Own Shares
28th Dec 20237:00 amRNSTransaction in Own Shares
27th Dec 20237:00 amRNSTransaction in Own Shares
22nd Dec 20237:00 amRNSTransaction in Own Shares
21st Dec 20237:00 amRNSTransaction in Own Shares
20th Dec 20238:00 amRNSShare Buyback Programme - Second Tranche
20th Dec 20237:00 amRNSTransaction in Own Shares
19th Dec 20237:00 amRNSTransaction in Own Shares
18th Dec 20237:00 amRNSTransaction in Own Shares
15th Dec 20237:00 amRNSTransaction in Own Shares
14th Dec 20237:00 amRNSTransaction in Own Shares
13th Dec 20237:00 amRNSTransaction in Own Shares
12th Dec 20236:13 pmRNSDirector/PDMR Shareholding
12th Dec 20237:00 amRNSTransaction in Own Shares
11th Dec 20237:00 amRNSTransaction in Own Shares
8th Dec 20237:00 amRNSTransaction in Own Shares
7th Dec 20237:00 amRNSTransaction in Own Shares
6th Dec 20237:00 amRNSTransaction in Own Shares
5th Dec 20237:00 amRNSTransaction in Own Shares
4th Dec 20237:00 amRNSTransaction in Own Shares
1st Dec 20231:40 pmRNSTotal Voting Rights
1st Dec 20237:00 amRNSTransaction in Own Shares
30th Nov 202311:30 amRNSDirector Declaration
30th Nov 20237:00 amRNSTransaction in Own Shares
29th Nov 20237:00 amRNSTransaction in Own Shares
28th Nov 20237:00 amRNSTransaction in Own Shares
27th Nov 20237:00 amRNSTransaction in Own Shares
24th Nov 20237:00 amRNSTransaction in Own Shares
23rd Nov 20237:00 amRNSTransaction in Own Shares
22nd Nov 20237:00 amRNSAppointment of Senior Independent Director
22nd Nov 20237:00 amRNSTransaction in Own Shares
21st Nov 20237:00 amRNSTransaction in Own Shares
20th Nov 20237:00 amRNSTransaction in Own Shares
17th Nov 20237:00 amRNSTransaction in Own Shares
16th Nov 20237:00 amRNSTransaction in Own Shares
15th Nov 20237:00 amRNSChair Succession
15th Nov 20237:00 amRNSTransaction in Own Shares
14th Nov 20237:00 amRNSTransaction in Own Shares
13th Nov 20237:00 amRNSTransaction in Own Shares
10th Nov 20237:00 amRNSTransaction in Own Shares
9th Nov 20237:00 amRNSTransaction in Own Shares
8th Nov 20237:00 amRNSTransaction in Own Shares
7th Nov 20237:00 amRNSTransaction in Own Shares
6th Nov 20237:00 amRNSTransaction in Own Shares
3rd Nov 20237:05 amRNSTransaction in Own Shares
2nd Nov 20237:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.